GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (CHIX:ONTl) » Definitions » 10-Year Share Buyback Ratio

Oxford Nanopore Technologies (CHIX:ONTL) 10-Year Share Buyback Ratio : 0.00% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies 10-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Oxford Nanopore Technologies's current 10-Year Share Buyback Ratio was 0.00%.

CHIX:ONTl's 10-Year Share Buyback Ratio is not ranked *
in the Biotechnology industry.
Industry Median: -11.7
* Ranked among companies with meaningful 10-Year Share Buyback Ratio only.

Competitive Comparison of Oxford Nanopore Technologies's 10-Year Share Buyback Ratio

For the Biotechnology subindustry, Oxford Nanopore Technologies's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's 10-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's 10-Year Share Buyback Ratio falls into.


;
;

Oxford Nanopore Technologies 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Oxford Nanopore Technologies (CHIX:ONTl) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Oxford Nanopore Technologies 10-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's 10-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.

Oxford Nanopore Technologies Headlines

No Headlines